NextFin News - Oklo (OKLO) shares fell 9.3% on Tuesday, closing at $45.58, as the market struggled to reconcile a flurry of high-profile commercial milestones with the stark reality of the company’s current zero-revenue profile. The decline comes despite the advanced nuclear developer announcing an expanded strategic partnership with Sweden-based Blykalla AB and securing a critical prepaid power agreement with Meta Platforms to fund its first reactor campus in Ohio.
The deal with Meta, announced earlier this year and detailed in recent regulatory filings, involves a commitment to support a 1.2 GW nuclear power campus in Pike County, Ohio. According to reports from Utility Dive and The Motley Fool, Meta is effectively acting as a financier, using "prepaid power" to provide Oklo with the immediate liquidity required to break ground. This arrangement is part of a broader 6.6 GW nuclear procurement strategy by Meta, which also includes agreements with Vistra and TerraPower to meet the surging electricity demands of its AI data centers.
Simultaneously, Oklo and Blykalla AB confirmed on Monday an expansion of their transatlantic collaboration. The partnership focuses on fast reactor commercialization, with Blykalla providing technical support for neutronics and thermohydraulics analyses for Oklo’s Department of Energy-authorized pilot projects. In exchange, Oklo will offer fast-neutron irradiation testing at its U.S. facilities to assist Blykalla’s reactor development. While these moves solidify Oklo’s position in the "nuclear renaissance," the stock’s 41.4% year-to-date decline suggests investors are increasingly wary of the long lead times and regulatory hurdles inherent in the sector.
A widely followed valuation narrative from Simply Wall St currently pegs Oklo’s fair value at $112.13 per share, suggesting the stock is nearly 60% undervalued. This model relies heavily on Oklo’s vertically integrated fuel strategy, which includes the Advanced Fuel Center in Tennessee and the use of recycled nuclear fuel. The analysis assumes that securing a proprietary fuel supply will stabilize long-term costs and eventually lead to the high-growth margin profiles typically seen in software, rather than traditional utilities. However, this valuation is highly sensitive to federal program timelines and the successful fabrication of High-Assay Low-Enriched Uranium (HALEU).
The $112 price target represents a specific, optimistic scenario and does not reflect a broad Wall Street consensus. Most institutional analysts remain cautious, noting that Oklo has yet to receive full design approval from the Nuclear Regulatory Commission (NRC) for its commercial-scale Aurora reactor. While William Blair maintains an "Outperform" rating based on the Department of Energy’s preliminary safety approvals, other market participants point to the company’s ongoing operating losses and the risk that any regulatory delay could exhaust its cash reserves before the first kilowatt is sold.
The divergence in performance is striking: early investors have seen a three-year return exceeding 300%, yet those who entered during the 2025 AI-nuclear hype cycle are facing significant drawdowns. The Meta deal provides a much-needed capital bridge, but it also ties Oklo’s fate to the specific regional infrastructure of Southern Ohio and the continued appetite of Big Tech for carbon-free baseload power. For now, the market appears to be shifting its focus from the "if" of nuclear demand to the "when" of reactor delivery, a transition that often involves painful valuation resets for pre-revenue industrial firms.
Explore more exclusive insights at nextfin.ai.
